AHCO vs HCSG vs EHAB vs AMSF vs ADUS

For growth investors, Addus HomeCare Corporation (ADUS) is the stronger pick with 23.

2% revenue growth year-over-year, versus -0. 5% for AdaptHealth Corp. (AHCO). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate AdaptHealth Corp. (AHCO) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, AMERISAFE, Inc.

(AMSF) is the cheapest at 12. 3x versus Healthcare Services Group, Inc. at 27. 5x. On forward P/E, AdaptHealth Corp. is actually cheaper at 11. 7x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Addus HomeCare Corporation (ADUS) delivered a total return of +0.

0%, compared to -55. 5% for AdaptHealth Corp. (AHCO). Over 10 years, the gap is even starker: ADUS returned +399. 9% versus EHAB's -44. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), AMERISAFE, Inc.

(AMSF) is the lower-risk stock at 0. 23β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 386% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 125% for AdaptHealth Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Addus HomeCare Corporation (ADUS) is pulling ahead at 23.

2% versus -0. 5% for AdaptHealth Corp. (AHCO). On earnings-per-share growth, the picture is similar: Enhabit, Inc. grew EPS 97. 1% year-over-year, compared to -185. 2% for AdaptHealth Corp.. Over a 3-year CAGR, ADUS leads at 14. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

AMERISAFE, Inc.

(AMSF) is the more profitable company, earning 14. 9% net margin versus -2. 2% for AdaptHealth Corp. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 2. 6% for HCSG. At the gross margin level — before operating expenses — EHAB leads at 46. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, AdaptHealth Corp.

(AHCO) trades at 11. 7x forward P/E versus 22. 8x for Enhabit, Inc. — 11. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMSF: 46. 9% to $44. 50.

In this comparison, AMSF (8.

4% yield) pays a dividend. AHCO, HCSG, EHAB, ADUS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, AMERISAFE, Inc.

(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 8%, HCSG: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AHCO (Healthcare) and HCSG (Healthcare) and EHAB (Healthcare) and AMSF (Financial Services) and ADUS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AHCO is a small-cap quality compounder stock; HCSG is a small-cap quality compounder stock; EHAB is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock; ADUS is a small-cap high-growth stock. AMSF pays a dividend while AHCO, HCSG, EHAB, ADUS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.